Evaluation of GLUCOFACTS® Deluxe Diabetes Management System
NCT ID: NCT00892151
Last Updated: 2016-02-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2009-04-30
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Self-management Oriented Diabetes Education Program for Intensified Insulin Therapy in Type 2 Diabetes
NCT00901992
Diabetes Management in Low-Income Hispanic Patients
NCT00848315
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
NCT05893927
Nutritional Therapy and Education With Multimedia Application in Patients With Type 2 Diabetes
NCT02441023
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
NCT06899191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intended Users of the Software
10 Healthcare Professionals and 40 persons with diabetes (of which 6 were parents/legal guardians of children with diabetes) using a diabetes data management program.
GLUCOFACTS® Deluxe
Diabetes Data Management Software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GLUCOFACTS® Deluxe
Diabetes Data Management Software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 18 years of age (at least 80% must be 55 years or less)
* Have diabetes or be the parent or legal guardian of a child with diabetes who routinely test their blood sugar at home
* Be testing blood sugar at home at least twice daily for at least one month or be the parent or legal guardian of a child who has been testing blood sugar at home at least twice daily for at least one month
* Be able to speak, read, and understand English
* Have experience using PC programs or browsing the internet
* Have utilized diabetes management software at home in the last year (at least 75% of lay users) or be familiar with diabetes management software
HCPs must:
* Have experience using diabetes data management software in the medical office or assist in patients' diabetes disease management using software
Exclusion Criteria
* Person having a cognitive disorder or condition which, in the opinion of the investigator, would put the person at risk or compromise the integrity of the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ascensia Diabetes Care
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy Bailey, MD
Role: PRINCIPAL_INVESTIGATOR
AMCR Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AMCR Institute
Escondido, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTD-2009-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.